| Q4 2023 |
|
|
|
|
|
|
13F-NT |
2/9/2024, 02:22 PM |
| Q3 2023 |
49 |
$254M |
+$157M |
-$2.08M |
+$155M |
THRY, PDFS, ITI, INSE, ASPN
|
13F-HR |
11/14/2023, 12:40 PM |
| Q2 2023 |
12 |
$119M |
+$8.93M |
-$7.48M |
+$1.45M |
PDFS, THRY, ASPN, INSE, ITI
|
13F-HR |
8/9/2023, 05:17 PM |
| Q1 2023 |
13 |
$110M |
+$6.81M |
-$9.07M |
-$2.26M |
PDFS, THRY, ITI, INSE, ASPN
|
13F-HR |
5/10/2023, 11:20 AM |
| Q4 2022 |
13 |
$94.9M |
+$14.9M |
-$6.9M |
+$7.96M |
PDFS, THRY, ASPN, ITI, INSE
|
13F-HR |
2/8/2023, 10:30 AM |
| Q3 2022 |
10 |
$60.9M |
+$8.58M |
-$3.56M |
+$5.02M |
PDFS, ITI, GENI, INSE, ASPN
|
13F-HR |
11/7/2022, 10:47 AM |
| Q2 2022 |
17 |
$80M |
+$17.3M |
-$15M |
+$2.28M |
PDFS, THRY, ITI, SCOR, ASPN
|
13F-HR |
8/4/2022, 11:24 AM |
| Q1 2022 |
19 |
$117M |
+$16.4M |
-$3.41M |
+$13M |
PDFS, ASPN, RMBL, ITI, THRY
|
13F-HR |
5/16/2022, 10:58 AM |
| Q4 2021 |
18 |
$149M |
+$15.4M |
-$10.1M |
+$5.28M |
PDFS, ASPN, VG, THRY, RMBL
|
13F-HR |
2/8/2022, 10:17 AM |
| Q3 2021 |
19 |
$136M |
+$11.7M |
-$17.9M |
-$6.17M |
PDFS, ASPN, VG, QUOT, GTYH
|
13F-HR |
11/10/2021, 05:40 PM |
| Q2 2021 |
20 |
$148M |
+$23M |
-$10.5M |
+$12.5M |
QUOT, PDFS, VG, ASPN, INOV
|
13F-HR |
8/13/2021, 02:22 PM |
| Q1 2021 |
20 |
$135M |
+$21.3M |
-$23M |
-$1.69M |
QUOT, PDFS, INOV, VG, ITI
|
13F-HR |
5/12/2021, 12:41 PM |
| Q4 2020 |
18 |
$117M |
|
|
|
QUOT, PDFS, GAN, INOV, VG
|
13F-HR |
2/11/2021, 02:49 PM |